Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 27.02% is in line with its 5-year average of 26.00%, near the high end of its 5-year range (5.95%–30.10%).
28.83% above its 12-month average of 20.97%.
Reported quarterly EBITDA margin; no daily interpolation. Q3 FY2026 (2026-07-31): 20.82%.
EBITDA MARGIN
27.02%
EBITDA MARGIN AVG TTM
20.97%
EBITDA MARGIN AVG 3Y
26.41%
EBITDA MARGIN AVG 5Y
26.00%
EBITDA MARGIN AVG 10Y
27.19%
EBITDA MARGIN AVG 15Y
26.92%
EBITDA MARGIN AVG 20Y
25.60%
CURRENT VS TTM AVG
+28.83%
CURRENT VS 3Y AVG
+2.32%
CURRENT VS 5Y AVG
+3.92%
CURRENT VS 10Y AVG
-0.61%
CURRENT VS 15Y AVG
+0.36%
CURRENT VS 20Y AVG
+5.53%
The Cooper Companies, Inc.
Market Cap
$10.51B
EBITDA Margin
27.02%
TTM Avg
20.97%
3Y Avg
26.41%
5Y Avg
26.00%
Market Cap
$10.58B
EBITDA Margin
15.05%
TTM Avg
14.69%
3Y Avg
13.35%
5Y Avg
14.10%
Market Cap
$10.66B
EBITDA Margin
2.15%
TTM Avg
3.41%
3Y Avg
4.20%
5Y Avg
4.49%
Market Cap
$10.34B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
Market Cap
$10.80B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$10.14B
EBITDA Margin
10.47%
TTM Avg
10.43%
3Y Avg
10.38%
5Y Avg
10.85%
Market Cap
$10.01B
EBITDA Margin
20.41%
TTM Avg
18.54%
3Y Avg
20.94%
5Y Avg
21.85%
Market Cap
$9.94B
EBITDA Margin
18.42%
TTM Avg
17.41%
3Y Avg
19.12%
5Y Avg
20.05%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $10.51B | 27.02% | 20.97% | 26.41% | 26.00% |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 15.05% | 14.69% | 13.35% | 14.10% |
| Molina Healthcare, Inc. (MOH)vs › | $10.66B | 2.15% | 3.41% | 4.20% | 4.49% |
| Tempus AI, Inc. (TEM)vs › | $10.34B | -11.84% | -53.07% | -52.51% | -64.32% |
| Align Technology, Inc. (ALGN)vs › | $10.80B | 19.75% | 19.29% | 19.87% | 21.06% |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 10.47% | 10.43% | 10.38% | 10.85% |
| Henry Schein, Inc. (HSIC)vs › | $10.07B | 8.11% | 8.11% | 8.28% | 8.19% |
| Globus Medical, Inc. (GMED)vs › | $10.01B | 20.41% | 18.54% | 20.94% | 21.85% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.94B | 18.42% | 17.41% | 19.12% | 20.05% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 28.74% | 23.07% | 27.33% | 30.04% |
Gross Margin
64.8%
EBITDA Margin
27.0%
Operating Margin
12.8%
Net Margin
13.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-07-31 | 20.82% |
| 2026-04-30 | 5.95% |
| 2026-01-31 | 30.10% |
| 2025-10-31 | 22.42% |
| 2025-07-31 | 25.57% |
| 2025-04-30 | 27.68% |
| 2025-01-31 | 28.30% |
| 2024-10-31 | 28.42% |
| 2024-07-31 | 28.07% |
| 2024-04-30 | 27.58% |
| 2024-01-31 | 26.82% |
| 2023-10-31 | 24.64% |
| 2023-07-31 | 26.46% |
| 2023-04-30 | 21.32% |
| 2023-01-31 | 27.86% |
| 2022-10-31 | 22.70% |
| 2022-07-31 | 26.36% |
| 2022-04-30 | 27.25% |
| 2022-01-31 | 27.03% |
| 2021-10-31 | 27.12% |
| 2021-07-31 | 23.51% |
| 2021-04-30 | 30.67% |
| 2021-01-31 | 30.70% |
| 2020-10-31 | 26.00% |
| 2020-07-31 | 24.66% |
| 2020-04-30 | 18.56% |
| 2020-01-31 | 28.12% |
| 2019-10-31 | 31.41% |
| 2019-07-31 | 31.34% |
| 2019-04-30 | 33.26% |
| 2019-01-31 | 28.61% |
| 2018-10-31 | 29.65% |
| 2018-07-31 | 27.97% |
| 2018-04-30 | 22.76% |
| 2018-01-31 | 26.58% |
| 2017-10-31 | 27.73% |
| 2017-07-31 | 28.78% |
| 2017-04-30 | 31.26% |
| 2017-01-31 | 27.75% |
| 2016-10-31 | 23.43% |
| 2016-07-31 | 29.57% |
| 2016-04-30 | 28.46% |
| 2016-01-31 | 24.66% |
| 2015-10-31 | 20.27% |
| 2015-07-31 | 22.57% |
| 2015-04-30 | 26.57% |
| 2015-01-31 | 26.06% |
| 2014-10-31 | 17.51% |
| 2014-07-31 | 29.84% |
| 2014-04-30 | 29.27% |
| 2014-01-31 | 27.91% |
| 2013-10-31 | 22.78% |
| 2013-07-31 | 30.27% |
| 2013-04-30 | 29.27% |
| 2013-01-31 | 26.42% |
| 2012-10-31 | 27.71% |
| 2012-07-31 | 27.78% |
| 2012-04-30 | 26.75% |
| 2012-01-31 | 26.85% |
| 2011-10-31 | 25.76% |
| 2011-07-31 | 22.02% |
| 2011-04-30 | 25.75% |
| 2011-01-31 | 24.42% |
| 2010-10-31 | 27.36% |
| 2010-07-31 | 25.47% |
| 2010-04-30 | 21.79% |
| 2010-01-31 | 23.01% |
| 2009-10-31 | 23.48% |
| 2009-07-31 | 19.60% |
| 2009-04-30 | 23.87% |
| 2009-01-31 | 23.01% |
| 2008-10-31 | 25.03% |
| 2008-07-31 | 18.30% |
| 2008-04-30 | 18.78% |
| 2008-01-31 | 16.35% |
| 2007-10-31 | 9.76% |
| 2007-07-31 | 18.41% |
| 2007-04-30 | 12.15% |
| 2007-01-31 | 14.51% |
| 2006-10-31 | 18.07% |
| 2006-07-31 | 21.28% |
| 2006-04-30 | 122.79% |
| 2006-01-31 | 23.28% |
| 2005-10-31 | 17.27% |
| 2005-07-31 | 26.83% |
| 2005-04-30 | 24.85% |
| 2005-01-31 | 23.53% |
| 2004-10-31 | 27.91% |
| 2004-07-31 | 27.65% |
| 2004-04-30 | 26.35% |
| 2004-01-31 | 25.92% |
| 2003-10-31 | 28.66% |
| 2003-07-31 | 26.25% |
| 2003-04-30 | 25.04% |
| 2003-01-31 | 24.24% |
| 2002-10-31 | 26.48% |
